Medimaging Integrated Solution Inc. (TPE:6796)
Taiwan · Delayed Price · Currency is TWD 95.20
+1.00 (1.06%)
Jan 2, 2026, 1:35 PM CST
TPE:6796 Revenue
Medimaging Integrated Solution had revenue of 152.79M TWD in the quarter ending September 30, 2025, with 46.72% growth. This brings the company's revenue in the last twelve months to 656.21M, up 38.48% year-over-year. In the year 2024, Medimaging Integrated Solution had annual revenue of 538.92M with 0.33% growth.
Revenue (ttm)
656.21M
Revenue Growth
+38.48%
P/S Ratio
5.49
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 538.92M | 1.77M | 0.33% |
| Dec 31, 2023 | 537.15M | 35.06M | 6.98% |
| Dec 31, 2022 | 502.09M | 16.22M | 3.34% |
| Dec 31, 2021 | 485.87M | 83.40M | 20.72% |
| Dec 31, 2020 | 402.47M | 87.97M | 27.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Pegavision | 6.90B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |